{"recordsFiltered":49280,"recordsTotal":49280,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=status&start=41700","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=status&start=41100","results":[{"registry_id":"NCT05393804","publication_url":"https://clinicaltrials.gov/study/NCT05393804","title":"Feasibility Trial of Autologous Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy Using Ide-Cel for Multiple Myeloma Patients Status Post Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2022-05-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05356104","publication_url":"https://clinicaltrials.gov/study/NCT05356104","title":"GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) - A Pilot Study","has_exemption":false,"start_date":"2022-05-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05379985","publication_url":"https://clinicaltrials.gov/study/NCT05379985","title":"A Multicenter Open-Label Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS","has_exemption":false,"start_date":"2022-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03828201","publication_url":"https://clinicaltrials.gov/study/NCT03828201","title":"Prospective, Randomized, Partially Blinded, Phase 2 Study of the Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine for Treatment of Patients With MDR-TB","has_exemption":false,"start_date":"2022-06-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston University","sponsor_slug":"boston-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05429632","publication_url":"https://clinicaltrials.gov/study/NCT05429632","title":"Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Mocravimod as Adjunctive and Maintenance Treatment in Adult AML Patients Undergoing Allogeneic HCT","has_exemption":false,"start_date":"2022-06-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Priothera SAS","sponsor_slug":"priothera-sas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254327","publication_url":"https://clinicaltrials.gov/study/NCT05254327","title":"A Randomized Phase 2 Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With and Without BMX-001 as Part of Total Neoadjuvant Therapy in Patients With Newly Diagnosed Locally Advanced Rectal Adenocarcinoma","has_exemption":false,"start_date":"2022-08-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318417","publication_url":"https://clinicaltrials.gov/study/NCT05318417","title":"A Post-approval, Prospective, Nonrandomized, Single-arm Multicenter Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness","has_exemption":false,"start_date":"2022-08-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Cochlear","sponsor_slug":"cochlear","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05427708","publication_url":"https://clinicaltrials.gov/study/NCT05427708","title":"Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety: A Randomized Clinical Trial","has_exemption":false,"start_date":"2022-08-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05272254","publication_url":"https://clinicaltrials.gov/study/NCT05272254","title":"Povidone Iodine Efficacy Study","has_exemption":false,"start_date":"2022-09-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05456321","publication_url":"https://clinicaltrials.gov/study/NCT05456321","title":"tDCS and Cognitive Training as a Neurodevelopmental Intervention in FASD","has_exemption":false,"start_date":"2022-11-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05378347","publication_url":"https://clinicaltrials.gov/study/NCT05378347","title":"Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression","has_exemption":false,"start_date":"2023-01-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiovascular","sponsor_slug":"medtronic-cardiovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111729","publication_url":"https://clinicaltrials.gov/study/NCT06111729","title":"Habit Awareness Device for Treatment of Onychophagia","has_exemption":false,"start_date":"2023-01-24","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05375968","publication_url":"https://clinicaltrials.gov/study/NCT05375968","title":"Mechanism of Glucose-dependent Insulinotropic Polypeptide (GIP) on Splanchnic Venous Capacitance in Postural Tachycardia Syndrome","has_exemption":false,"start_date":"2023-02-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06874855","publication_url":"https://clinicaltrials.gov/study/NCT06874855","title":"Lemborexant in Delayed Sleep Phase Syndrome","has_exemption":false,"start_date":"2023-03-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05562167","publication_url":"https://clinicaltrials.gov/study/NCT05562167","title":"The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF) -a Phase II Clinical Trial","has_exemption":false,"start_date":"2023-03-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05500963","publication_url":"https://clinicaltrials.gov/study/NCT05500963","title":"Reducing Fatigue in People With Multiple Sclerosis by Treatment With Transcutaneous Electrical Nerve Stimulation","has_exemption":false,"start_date":"2023-04-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Boulder","sponsor_slug":"university-of-colorado-boulder","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05671861","publication_url":"https://clinicaltrials.gov/study/NCT05671861","title":"Design of a Low-Cost Therapeutic Device for Patients With Radiation-Related Trismus","has_exemption":false,"start_date":"2023-04-27","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05489523","publication_url":"https://clinicaltrials.gov/study/NCT05489523","title":"An Open-label Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation","has_exemption":false,"start_date":"2023-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05794880","publication_url":"https://clinicaltrials.gov/study/NCT05794880","title":"Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies With Targeted ATG Dosing Pilot Study, IDE 13641","has_exemption":false,"start_date":"2023-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05716516","publication_url":"https://clinicaltrials.gov/study/NCT05716516","title":"Phase II Study of Estradiol Therapy to Target ER-Mutant and ER-Wild-Type ER+ Metastatic or Advanced Breast Cancer","has_exemption":false,"start_date":"2023-05-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05295680","publication_url":"https://clinicaltrials.gov/study/NCT05295680","title":"A Study of Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis(HAAPS Study).","has_exemption":false,"start_date":"2023-05-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Aparna Goel","sponsor_slug":"aparna-goel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05851924","publication_url":"https://clinicaltrials.gov/study/NCT05851924","title":"Total Neoadjuvant NALIRIFOX Plus Ablative Dose Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2023-05-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05209165","publication_url":"https://clinicaltrials.gov/study/NCT05209165","title":"Semaglutide as Treatment of Overweight and Obese Individuals to Reduce Atrial Fibrillation Burden","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"San Francisco Veterans Affairs Medical Center","sponsor_slug":"san-francisco-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05881408","publication_url":"https://clinicaltrials.gov/study/NCT05881408","title":"A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP- 9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Sarepta Therapeutics, Inc.","sponsor_slug":"sarepta-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06231342","publication_url":"https://clinicaltrials.gov/study/NCT06231342","title":"Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion to Decrease the Risk of Postoperative Sore Throat: a Randomized Double-Blind Prospective Trial.","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05694871","publication_url":"https://clinicaltrials.gov/study/NCT05694871","title":"Official Title A Randomized Phase 2 Trial With a Safety Lead-In to Evaluate Palbociclib Versus Palbociclib and Cemiplimab for the Treatment of Advanced Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2023-06-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05845814","publication_url":"https://clinicaltrials.gov/study/NCT05845814","title":"A Phase 1/2 Randomized, Umbrella Study to Evaluate the Safety and Efficacy of Pembrolizumab Plus Enfortumab Vedotin (EV) in Combination With Investigational Agents Versus Pembrolizumab Plus EV, as First-Line Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04B","has_exemption":false,"start_date":"2023-06-23","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05873218","publication_url":"https://clinicaltrials.gov/study/NCT05873218","title":"Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After Combined Spinal Epidural on Laboring Parturients","has_exemption":false,"start_date":"2023-06-26","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05801939","publication_url":"https://clinicaltrials.gov/study/NCT05801939","title":"Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2023-07-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05819866","publication_url":"https://clinicaltrials.gov/study/NCT05819866","title":"A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy","has_exemption":false,"start_date":"2023-07-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Minoryx Therapeutics, S.L.","sponsor_slug":"minoryx-therapeutics-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066645","publication_url":"https://clinicaltrials.gov/study/NCT06066645","title":"Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite in Subjects With Open-angle Glaucoma or Ocular Hypertension","has_exemption":false,"start_date":"2023-09-14","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05816122","publication_url":"https://clinicaltrials.gov/study/NCT05816122","title":"MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect","has_exemption":false,"start_date":"2023-09-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Ad scientiam","sponsor_slug":"ad-scientiam","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05851976","publication_url":"https://clinicaltrials.gov/study/NCT05851976","title":"Duloxetine for Patients With Low Back Pain Who Fail to Improve With Oral NSAIDs. A Randomized Placebo-controlled Exploratory Study","has_exemption":false,"start_date":"2023-10-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06040320","publication_url":"https://clinicaltrials.gov/study/NCT06040320","title":"A Phase I/II Study of Frontline Therapy With Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)","has_exemption":false,"start_date":"2023-10-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05853601","publication_url":"https://clinicaltrials.gov/study/NCT05853601","title":"Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage","has_exemption":false,"start_date":"2023-10-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938465","publication_url":"https://clinicaltrials.gov/study/NCT05938465","title":"A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis (PROF). The \"PROF\" Study.","has_exemption":false,"start_date":"2023-11-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Exegi Pharma, LLC","sponsor_slug":"exegi-pharma-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05589818","publication_url":"https://clinicaltrials.gov/study/NCT05589818","title":"A Phase II Study of the Effects of Pembrolizumab on Quality of Life for Patients With Treatment-Naïve, Advanced or Metastatic NSCLC and Poor Performance Status","has_exemption":false,"start_date":"2023-12-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05769153","publication_url":"https://clinicaltrials.gov/study/NCT05769153","title":"A Phase 1/2 Two-Stage Dose Escalation and Randomized Parallel-Group Study to Evaluate the Safety, Preliminary Treatment Effects, and Durability of AR-14034 Sustained Release Implant Compared to Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Participants With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06137274","publication_url":"https://clinicaltrials.gov/study/NCT06137274","title":"Phase 2 Trial of Adaptive Radiotherapy Boost for Head and Neck Squamous Cell Carcinomas","has_exemption":false,"start_date":"2023-12-14","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05766371","publication_url":"https://clinicaltrials.gov/study/NCT05766371","title":"A Phase 2 Study of Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-12-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06082518","publication_url":"https://clinicaltrials.gov/study/NCT06082518","title":"Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (PCS-HBOT Study)","has_exemption":false,"start_date":"2024-01-02","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Sunnybrook Health Sciences Centre","sponsor_slug":"sunnybrook-health-sciences-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06128915","publication_url":"https://clinicaltrials.gov/study/NCT06128915","title":"The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses","has_exemption":false,"start_date":"2024-01-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05903859","publication_url":"https://clinicaltrials.gov/study/NCT05903859","title":"Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)","has_exemption":false,"start_date":"2024-01-18","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06169124","publication_url":"https://clinicaltrials.gov/study/NCT06169124","title":"A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination With Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell Tumor","has_exemption":false,"start_date":"2024-02-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06120140","publication_url":"https://clinicaltrials.gov/study/NCT06120140","title":"A Phase 2, Open-Label, Randomized Trial Evaluating the Impact of Enhanced Versus Standard Dermatologic Management on Selected Dermatologic Adverse Events Among Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC Treated First-Line With Amivantamab + Lazertinib","has_exemption":false,"start_date":"2024-02-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05483010","publication_url":"https://clinicaltrials.gov/study/NCT05483010","title":"Pilot Study of Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)","has_exemption":false,"start_date":"2024-02-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05701111","publication_url":"https://clinicaltrials.gov/study/NCT05701111","title":"Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress","has_exemption":false,"start_date":"2024-02-23","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003153","publication_url":"https://clinicaltrials.gov/study/NCT06003153","title":"GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH","has_exemption":false,"start_date":"2024-03-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06232577","publication_url":"https://clinicaltrials.gov/study/NCT06232577","title":"5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-03-27","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06319027","publication_url":"https://clinicaltrials.gov/study/NCT06319027","title":"Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)","has_exemption":false,"start_date":"2024-04-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06338995","publication_url":"https://clinicaltrials.gov/study/NCT06338995","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants With Chronic Rhinosinusitis With Nasal Polyps on Background Intranasal Corticosteroids","has_exemption":false,"start_date":"2024-04-29","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05880810","publication_url":"https://clinicaltrials.gov/study/NCT05880810","title":"Continuous Glucose Monitor Use for Mayo Clinic Advanced Care at Home Patients With Diabetes Mellitus","has_exemption":false,"start_date":"2024-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214949","publication_url":"https://clinicaltrials.gov/study/NCT06214949","title":"Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) as a Treatment for Chronic Neck Pain","has_exemption":false,"start_date":"2024-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","sponsor_slug":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06237868","publication_url":"https://clinicaltrials.gov/study/NCT06237868","title":"The Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Impulse Control Disorders in Parkinson's Disease Patients on Dopamine Replacement Therapy.","has_exemption":false,"start_date":"2024-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05800210","publication_url":"https://clinicaltrials.gov/study/NCT05800210","title":"Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases","has_exemption":false,"start_date":"2024-05-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06249048","publication_url":"https://clinicaltrials.gov/study/NCT06249048","title":"A Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of STX-001 Delivered by Intratumoral Injection in Patients With Advanced Solid Tumors as a Monotherapy or in Combination With Pembrolizumab","has_exemption":false,"start_date":"2024-05-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Strand Therapeutics Inc.","sponsor_slug":"strand-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411821","publication_url":"https://clinicaltrials.gov/study/NCT06411821","title":"Phase 2 Trial of Ulixertinib for Patients With Histiocytic Neoplasms","has_exemption":false,"start_date":"2024-05-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364176","publication_url":"https://clinicaltrials.gov/study/NCT06364176","title":"Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis","has_exemption":false,"start_date":"2024-06-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411249","publication_url":"https://clinicaltrials.gov/study/NCT06411249","title":"A Phase 4, Multicenter, Prospective, Open-Label Study Describing the Efficacy and Safety of Belimumab Administered Subcutaneously in Adult Participants With Early Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2024-06-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06259006","publication_url":"https://clinicaltrials.gov/study/NCT06259006","title":"TREAT-SC: A Randomised, Double-Blinded, Placebo-Controlled Trial of Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children","has_exemption":false,"start_date":"2024-06-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Starship Child Health, Te Toka Tumai Auckland","sponsor_slug":"starship-child-health-te-toka-tumai-auckland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776641","publication_url":"https://clinicaltrials.gov/study/NCT05776641","title":"Prevention of Alzheimer's Disease Using Gamma Entrainment","has_exemption":false,"start_date":"2024-06-21","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06456580","publication_url":"https://clinicaltrials.gov/study/NCT06456580","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2024-07-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vor Biopharma","sponsor_slug":"vor-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06397911","publication_url":"https://clinicaltrials.gov/study/NCT06397911","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-08-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Oneness Biotech Co., Ltd.","sponsor_slug":"oneness-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06351111","publication_url":"https://clinicaltrials.gov/study/NCT06351111","title":"Vagus Nerve Stimulation (VNS) in Spinal Cord Injury (SCI) Adaptive Follow-On Study","has_exemption":false,"start_date":"2024-08-29","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06247098","publication_url":"https://clinicaltrials.gov/study/NCT06247098","title":"Sinus Augmentation Healing With Autogenous and Xenograft Mix Compared to Xenograft Alone","has_exemption":false,"start_date":"2024-09-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Tufts University","sponsor_slug":"tufts-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06325813","publication_url":"https://clinicaltrials.gov/study/NCT06325813","title":"ADHD PreSMA Response Inhibition Therapy","has_exemption":false,"start_date":"2024-09-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05708755","publication_url":"https://clinicaltrials.gov/study/NCT05708755","title":"Cytomegalovirus T Cell Immunity and Antiviral Prophylaxis Minimization in Lung Transplant Recipients","has_exemption":false,"start_date":"2024-09-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06628908","publication_url":"https://clinicaltrials.gov/study/NCT06628908","title":"A Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy","has_exemption":false,"start_date":"2024-10-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06672055","publication_url":"https://clinicaltrials.gov/study/NCT06672055","title":"A Phase 2b, Double-Blind, Multi-Center, Randomized, Comparator-Controlled Trial to Determine the Relative Efficacy, Safety, and Immunogenicity of the Investigational Oral SARS-CoV-2 Vaccine Tablet Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection","has_exemption":false,"start_date":"2024-10-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vaxart","sponsor_slug":"vaxart","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609577","publication_url":"https://clinicaltrials.gov/study/NCT06609577","title":"Personalized Ultrasound Guided Pacing of the External Diaphragm to Improve Outcomes in Patients Undergoing Invasive Mechanical Ventilation: a Randomized Controlled Trial","has_exemption":false,"start_date":"2024-11-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Daishan Jiang","sponsor_slug":"daishan-jiang","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06710288","publication_url":"https://clinicaltrials.gov/study/NCT06710288","title":"A Phase 2, Open-label, Single-arm Study Of Autologous Memory Cytokine Enriched Natural Killer (M-CENK) Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer","has_exemption":false,"start_date":"2024-11-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06537414","publication_url":"https://clinicaltrials.gov/study/NCT06537414","title":"A Phase 2b, Multi-centre, Randomized, Partially Placebo-controlled, Double-blind Study to Investigate the Safety and Efficacy of Sequential Therapy With Daplusiran/Tomligisiran Followed by Bepirovirsen in Participants With Chronic Hepatitis B Virus on Background Nucleos(t)Ide Analogue Therapy (B-United)","has_exemption":false,"start_date":"2024-11-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06191848","publication_url":"https://clinicaltrials.gov/study/NCT06191848","title":"Effect of Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2024-11-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Melbourne","sponsor_slug":"university-of-melbourne","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702449","publication_url":"https://clinicaltrials.gov/study/NCT06702449","title":"A Seamless Phase 1/2, Observer-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety and Immunogenicity of a UTI Vaccine When Administered to Adults 18 Through 64 Years of Age and Clinical Efficacy When Administered to Females 18 Through 64 Years of Age","has_exemption":false,"start_date":"2024-11-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588686","publication_url":"https://clinicaltrials.gov/study/NCT06588686","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People With Idiopathic Pulmonary Fibrosis.","has_exemption":false,"start_date":"2024-12-09","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vicore Pharma AB","sponsor_slug":"vicore-pharma-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06718101","publication_url":"https://clinicaltrials.gov/study/NCT06718101","title":"A Phase 2 Multicenter Platform Trial of Targeted Immunomodulator Therapies for Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-12-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06672016","publication_url":"https://clinicaltrials.gov/study/NCT06672016","title":"A Phase 3, Multicenter, Open-Label, Single-Arm Study of MR-130A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety","has_exemption":false,"start_date":"2025-01-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mylan Pharmaceuticals Inc","sponsor_slug":"mylan-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06648642","publication_url":"https://clinicaltrials.gov/study/NCT06648642","title":"An Open-label Clinical Trial of IR-TMS for AUD and Development of a Neurobiological Biomarker for Craving and Relapse Validated Using a Direct Biochemical Biomarker (Phosphatidylethanol) of Alcohol Use","has_exemption":false,"start_date":"2025-02-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06843239","publication_url":"https://clinicaltrials.gov/study/NCT06843239","title":"A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Zura Bio Inc","sponsor_slug":"zura-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05837845","publication_url":"https://clinicaltrials.gov/study/NCT05837845","title":"A Randomized Trial to Compare MDMA-assisted Cognitive Processing Therapy (aCPT) Versus a VA Standard-of-care CPT for the Treatment of Severe Posttraumatic Stress Disorder Among Veterans","has_exemption":false,"start_date":"2025-02-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Patricia Suppes","sponsor_slug":"patricia-suppes","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05455359","publication_url":"https://clinicaltrials.gov/study/NCT05455359","title":"The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms","has_exemption":false,"start_date":"2025-02-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06909825","publication_url":"https://clinicaltrials.gov/study/NCT06909825","title":"A Phase 2, Open-label, Multi-centre Study of FPI-2265 (225Ac-PSMA-I&T) and Olaparib in Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-02-26","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Fusion Pharmaceuticals Inc.","sponsor_slug":"fusion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798844","publication_url":"https://clinicaltrials.gov/study/NCT06798844","title":"Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease","has_exemption":false,"start_date":"2025-02-28","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Universitaire Ziekenhuizen KU Leuven","sponsor_slug":"universitaire-ziekenhuizen-ku-leuven","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05492266","publication_url":"https://clinicaltrials.gov/study/NCT05492266","title":"Expiratory Muscle Strength Training as a Non-surgical Option for Velopharyngeal Dysfunction: A Randomized-controlled Trial","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Noel Jabbour","sponsor_slug":"noel-jabbour","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06874621","publication_url":"https://clinicaltrials.gov/study/NCT06874621","title":"VY7523-102: A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Ascending Intravenous Doses of VY7523 in Participants With Early Alzheimer's Disease","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Voyager Therapeutics","sponsor_slug":"voyager-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792695","publication_url":"https://clinicaltrials.gov/study/NCT06792695","title":"A Phase II, Open-label, Multicenter, Master Protocol to Evaluate the Safety and Efficacy of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (CANTOR)","has_exemption":false,"start_date":"2025-03-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06843577","publication_url":"https://clinicaltrials.gov/study/NCT06843577","title":"A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects","has_exemption":false,"start_date":"2025-03-27","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Zona Health, Inc","sponsor_slug":"zona-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06568601","publication_url":"https://clinicaltrials.gov/study/NCT06568601","title":"Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858111","publication_url":"https://clinicaltrials.gov/study/NCT06858111","title":"Phase III Randomized Control Trial to Investigate the Safety and Efficacy of Fertilo Versus Medicult In Vitro Maturation (IVM)","has_exemption":false,"start_date":"2025-04-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Gameto, Inc.","sponsor_slug":"gameto-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919926","publication_url":"https://clinicaltrials.gov/study/NCT06919926","title":"A Randomized, Within-subject, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of AGB101 (Low-dose Levetiracetam, 220 mg, Extended Release Tablet) for the Treatment of Hippocampal Overactivity in the Elderly","has_exemption":false,"start_date":"2025-04-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06820177","publication_url":"https://clinicaltrials.gov/study/NCT06820177","title":"Prophylactic Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-04-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06988670","publication_url":"https://clinicaltrials.gov/study/NCT06988670","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism","has_exemption":false,"start_date":"2025-05-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Extend Biosciences Inc.","sponsor_slug":"extend-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06935357","publication_url":"https://clinicaltrials.gov/study/NCT06935357","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL)","has_exemption":false,"start_date":"2025-05-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010029","publication_url":"https://clinicaltrials.gov/study/NCT07010029","title":"Coronary Sinus Reducer in Patients With Angina With no Obstructive Coronary Disease: a Prospective Single-arm Study","has_exemption":false,"start_date":"2025-05-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of Warsaw","sponsor_slug":"medical-university-of-warsaw","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824454","publication_url":"https://clinicaltrials.gov/study/NCT06824454","title":"Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients","has_exemption":false,"start_date":"2025-05-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07197268","publication_url":"https://clinicaltrials.gov/study/NCT07197268","title":"An Open-Label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for Bainbridge-Ropers Syndrome Due to ASXL3 Gene Variant","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06996379","publication_url":"https://clinicaltrials.gov/study/NCT06996379","title":"Use of the J-Tip Needle-Free Injection System With 1% Lidocaine to Reduce Paracentesis-Related Discomfort","has_exemption":false,"start_date":"2025-05-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06921837","publication_url":"https://clinicaltrials.gov/study/NCT06921837","title":"A Phase 1/2, First-in-Human, Dose Escalation and Expansion Study of BDC-4182 as a Single Agent in Patients With Advanced Gastric and Gastroesophageal Cancer","has_exemption":false,"start_date":"2025-05-26","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Bolt Biotherapeutics, Inc.","sponsor_slug":"bolt-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06729996","publication_url":"https://clinicaltrials.gov/study/NCT06729996","title":"Randomized, Parallel Group, Dose Escalation Trial of Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus: The PEP-DM Trial","has_exemption":false,"start_date":"2025-05-29","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204912","publication_url":"https://clinicaltrials.gov/study/NCT07204912","title":"Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks","has_exemption":false,"start_date":"2025-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07018323","publication_url":"https://clinicaltrials.gov/study/NCT07018323","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease","has_exemption":false,"start_date":"2025-06-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092059","publication_url":"https://clinicaltrials.gov/study/NCT07092059","title":"Decentralized Clinical Trial of Contingency Management Digital Therapeutic to Treat Stimulant Use Disorder","has_exemption":false,"start_date":"2025-06-24","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"DynamiCare Health","sponsor_slug":"dynamicare-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976347","publication_url":"https://clinicaltrials.gov/study/NCT05976347","title":"Identifying and Treating Depression in the Orthopaedic Trauma Population","has_exemption":false,"start_date":"2025-06-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076407","publication_url":"https://clinicaltrials.gov/study/NCT07076407","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder","has_exemption":false,"start_date":"2025-07-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07103668","publication_url":"https://clinicaltrials.gov/study/NCT07103668","title":"An Open-label, Randomized, Comparative Phase III Study Including Patients With CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer.","has_exemption":false,"start_date":"2025-08-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Suzhou Immunofoco Biotechnology Co., Ltd","sponsor_slug":"suzhou-immunofoco-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161700","publication_url":"https://clinicaltrials.gov/study/NCT07161700","title":"A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults With Major Depressive Disorder, With or Without Anxious Distress","has_exemption":false,"start_date":"2025-09-02","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Seaport Therapeutics","sponsor_slug":"seaport-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915454","publication_url":"https://clinicaltrials.gov/study/NCT06915454","title":"High-resolution Specimen PET-CT Imaging for the Intraoperative Visualization of Resection Margins: an Exploratory Study","has_exemption":false,"start_date":"2025-09-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222163","publication_url":"https://clinicaltrials.gov/study/NCT07222163","title":"Stuttering and Neuromodulation","has_exemption":false,"start_date":"2025-09-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07397806","publication_url":"https://clinicaltrials.gov/study/NCT07397806","title":"Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis","has_exemption":false,"start_date":"2025-09-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Steadman Philippon Research Institute","sponsor_slug":"steadman-philippon-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052254","publication_url":"https://clinicaltrials.gov/study/NCT06052254","title":"A Double-Blind, Placebo-Controlled Evaluation of the Dexmedetomidine Transdermal Systems for Agitation Associated With Dementia of the Alzheimer's Type","has_exemption":false,"start_date":"2025-09-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Teikoku Pharma USA, Inc.","sponsor_slug":"teikoku-pharma-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06776783","publication_url":"https://clinicaltrials.gov/study/NCT06776783","title":"A Randomized, Controlled, Blinded, Parallel Group Study of the Safety and Efficacy of APC-0101 (SF-RI 1 Surfactant for Inhalation Combined With a Dedicated Delivery System) in Preterm Infants With Respiratory Distress Syndrome","has_exemption":false,"start_date":"2025-09-24","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Aerogen Pharma Limited","sponsor_slug":"aerogen-pharma-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07195656","publication_url":"https://clinicaltrials.gov/study/NCT07195656","title":"Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) EVANESCE-II","has_exemption":false,"start_date":"2025-09-30","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"FemPulse Corporation","sponsor_slug":"fempulse-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06988488","publication_url":"https://clinicaltrials.gov/study/NCT06988488","title":"A Phase 1b/2a, Multicenter, Open-label Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2025-10-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06974604","publication_url":"https://clinicaltrials.gov/study/NCT06974604","title":"Prevention of Datopotamab Deruxtecan (TROP-2 Directed ADC) Associated Stomatitis in Patients With HER2-negative Metastatic Breast Cancer or Non-small Cell Lung Cancer Using Dexamethasone Mouthwash: a Single-arm, Phase 2 Trial (TROPION- DM, 2023-ESR-000087)","has_exemption":false,"start_date":"2025-10-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04750551","publication_url":"https://clinicaltrials.gov/study/NCT04750551","title":"BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment (Pilot).","has_exemption":false,"start_date":"2025-11-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06903819","publication_url":"https://clinicaltrials.gov/study/NCT06903819","title":"Ketamine's Impact on Opioid Use, Pain, and Mental Health in Polytraumatized Orthopedic Patients: A Randomized Controlled Trial (KOPM)","has_exemption":false,"start_date":"2025-11-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Texas Tech University Health Sciences Center","sponsor_slug":"texas-tech-university-health-sciences-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07154511","publication_url":"https://clinicaltrials.gov/study/NCT07154511","title":"Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments","has_exemption":false,"start_date":"2025-11-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Prabesh Kanel","sponsor_slug":"prabesh-kanel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07186101","publication_url":"https://clinicaltrials.gov/study/NCT07186101","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Active-Controlled Study of LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2025-11-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07195201","publication_url":"https://clinicaltrials.gov/study/NCT07195201","title":"Prospective Evaluation of Onlay Restorations Produced by Additive and Subtractive Manufacturing in Vital Posterior Teeth: A Split-Mouth","has_exemption":false,"start_date":"2025-11-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Ayse Tugba Erturk Avunduk","sponsor_slug":"ayse-tugba-erturk-avunduk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07073950","publication_url":"https://clinicaltrials.gov/study/NCT07073950","title":"A Randomised, Double-blind, Multi-centre, Placebo-controlled, Crossover Study to Assess the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler on Cardiac and Lung Function in Participants With Chronic Obstructive Pulmonary Disease and Hyperinflation","has_exemption":false,"start_date":"2025-11-24","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07144163","publication_url":"https://clinicaltrials.gov/study/NCT07144163","title":"A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atumelnant in Adult Participants With Classic Congenital Adrenal Hyperplasia (Calm-CAH)","has_exemption":false,"start_date":"2025-12-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05107934","publication_url":"https://clinicaltrials.gov/study/NCT05107934","title":"International, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis","has_exemption":false,"start_date":"2025-12-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"R-Pharm Overseas, Inc.","sponsor_slug":"r-pharm-overseas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224581","publication_url":"https://clinicaltrials.gov/study/NCT07224581","title":"A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder","has_exemption":false,"start_date":"2026-01-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"GRIN Therapeutics, Inc.","sponsor_slug":"grin-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907979","publication_url":"https://clinicaltrials.gov/study/NCT06907979","title":"Experimental Manipulation of the Emotional Salience of Cannabis Use-Related Information in Regular Cannabis Users","has_exemption":false,"start_date":"2026-01-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Auburn University","sponsor_slug":"auburn-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424014","publication_url":"https://clinicaltrials.gov/study/NCT07424014","title":"Optimizing Mind-Body Interactions in Respiratory Control During Operationally Relevant Environmental Stressors","has_exemption":false,"start_date":"2026-02-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06840899","publication_url":"https://clinicaltrials.gov/study/NCT06840899","title":"Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury","has_exemption":false,"start_date":"2026-02-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07411859","publication_url":"https://clinicaltrials.gov/study/NCT07411859","title":"Reboot Pain: Integrating Neuromodulation Into Clinical Care for Military and Veterans With Chronic Pain","has_exemption":false,"start_date":"2026-02-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07458269","publication_url":"https://clinicaltrials.gov/study/NCT07458269","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes","has_exemption":false,"start_date":"2026-03-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Kailera","sponsor_slug":"kailera","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214675","publication_url":"https://clinicaltrials.gov/study/NCT07214675","title":"The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy","has_exemption":false,"start_date":"2026-03-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"HistoSonics, Inc.","sponsor_slug":"histosonics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07357428","publication_url":"https://clinicaltrials.gov/study/NCT07357428","title":"Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) to Provide Human Connection Through Communication","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Paradromics","sponsor_slug":"paradromics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523620","publication_url":"https://clinicaltrials.gov/study/NCT07523620","title":"Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07461662","publication_url":"https://clinicaltrials.gov/study/NCT07461662","title":"Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Mississippi Medical Center","sponsor_slug":"university-of-mississippi-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07455383","publication_url":"https://clinicaltrials.gov/study/NCT07455383","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 Study 302)","has_exemption":false,"start_date":"2026-04-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07533019","publication_url":"https://clinicaltrials.gov/study/NCT07533019","title":"A Phase 2, Randomized, 24-Week, Multicenter, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Non-Segmental Vitiligo","has_exemption":false,"start_date":"2026-04-14","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07502443","publication_url":"https://clinicaltrials.gov/study/NCT07502443","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 (Brilliance NT2 Study 303)","has_exemption":false,"start_date":"2026-04-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Alkermes, Inc.","sponsor_slug":"alkermes-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07515872","publication_url":"https://clinicaltrials.gov/study/NCT07515872","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"ZetrOZ, Inc.","sponsor_slug":"zetroz-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07548710","publication_url":"https://clinicaltrials.gov/study/NCT07548710","title":"Clinical Study of Sonrotoclax Combined With Azacitidine Plus Individualized Targeted Drugs in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Ruijin Hospital","sponsor_slug":"ruijin-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07570758","publication_url":"https://clinicaltrials.gov/study/NCT07570758","title":"A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Clinical Study to Assess Efficacy, Safety and Tolerability of Orally Administered ERX1000 in Subjects With Obesity","has_exemption":false,"start_date":"2026-05-28","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"ERX Pharmaceuticals","sponsor_slug":"erx-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979583","publication_url":"https://clinicaltrials.gov/study/NCT06979583","title":"Impact of Ureteral Stent Size on the Management of Post Ureteroscopy Pain: a Randomized Single Blind Trial","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07018206","publication_url":"https://clinicaltrials.gov/study/NCT07018206","title":"Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis (UP-FOR-U)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"CARE ARTHRITIS LTD.","sponsor_slug":"care-arthritis-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06855225","publication_url":"https://clinicaltrials.gov/study/NCT06855225","title":"A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab (STRIDE) Plus Gemcitabine and Cisplatin (GEMCIS) in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma (cHCC-CCA)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mehmet Akce","sponsor_slug":"mehmet-akce","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07487766","publication_url":"https://clinicaltrials.gov/study/NCT07487766","title":"A Phase 1/2, Single-Blinded Trial to Evaluate the Safety and Efficacy of Intra-Articular (IA) Injection of XytriX in Adult Subjects With Grade I-IV Knee Osteoarthritis (KOA)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"TricelX Inc.","sponsor_slug":"tricelx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07494136","publication_url":"https://clinicaltrials.gov/study/NCT07494136","title":"Dose Dependent Response to Interlaminar Steroid Injections for Lumbar Radiculopathy","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07507396","publication_url":"https://clinicaltrials.gov/study/NCT07507396","title":"Non-invasive Temperature Monitoring in Pediatric Intensive Care Patients Requiring Targeted Temperature Management: Evaluation of Temple Touch Pro","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07580963","publication_url":"https://clinicaltrials.gov/study/NCT07580963","title":"Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent Lengths","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07610473","publication_url":"https://clinicaltrials.gov/study/NCT07610473","title":"A Phase 2 Double-blind, Randomised, Placebo-controlled Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults With Major Depressive Disorder Receiving Pharmacological Therapy for Depression","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Draig Therapeutics Ltd","sponsor_slug":"draig-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140874","publication_url":"https://clinicaltrials.gov/study/NCT07140874","title":"Evaluation of Supplemental Zinc as an Adjunct to Prolong the Duration of Benefit After Botulinum Toxin Injections in Subjects With Cervical Dystonia","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542743","publication_url":"https://clinicaltrials.gov/study/NCT07542743","title":"A Novel Instrument to Address Freezing of Gait in Parkinson's Patients","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Barron Associates, Inc.","sponsor_slug":"barron-associates-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07267624","publication_url":"https://clinicaltrials.gov/study/NCT07267624","title":"EARLY Antibiotics aDaptation in Ventilator-Acquired-Pneumonia Treatment After Implementation of a Broad-Panel Respiratory Multiplex PCR Test: A Multicenter Randomized Control Trial Conducted In Swiss Intensive Care Units. The EARLY ADAPT Study.","has_exemption":false,"start_date":"2026-06-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Geneva","sponsor_slug":"university-hospital-geneva","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219654","publication_url":"https://clinicaltrials.gov/study/NCT07219654","title":"A Phase 2, Double-blinded, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Allogeneic Dermal Fibroblasts (TPX-115) in Patients With Partial-thickness Rotator Cuff Tear","has_exemption":false,"start_date":"2026-06-09","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Tego Science, Inc.","sponsor_slug":"tego-science-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364228","publication_url":"https://clinicaltrials.gov/study/NCT06364228","title":"Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia","has_exemption":false,"start_date":"2026-06-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07554443","publication_url":"https://clinicaltrials.gov/study/NCT07554443","title":"Wearable Sensory Prostheses to Improve Neuromuscular Coordination, Walking Function, and Real-World Physical Activity","has_exemption":false,"start_date":"2026-06-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"RxFunction Inc.","sponsor_slug":"rxfunction-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07469501","publication_url":"https://clinicaltrials.gov/study/NCT07469501","title":"Improving Buprenorphine Initiation Among Individuals With Opioid Use Disorder Using Fentanyl","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06362187","publication_url":"https://clinicaltrials.gov/study/NCT06362187","title":"A Feasibility Study on Gut-Directed Virtual Reality for Chronic Pain Related to Chronic Pancreatitis","has_exemption":false,"start_date":"2026-07-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140939","publication_url":"https://clinicaltrials.gov/study/NCT07140939","title":"A Phase 3, Randomized, Double-blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat.","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","sponsor_slug":"caliway-biopharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07486869","publication_url":"https://clinicaltrials.gov/study/NCT07486869","title":"Emapalumab for the Treatment of Anti-MDA5 Antibody Positive Rapidly Progressive Interstitial Lung Disease","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07613307","publication_url":"https://clinicaltrials.gov/study/NCT07613307","title":"A Phase 3b, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of Orforglipron in Adult Participants With Type 2 Diabetes Who Observe Ramadan Fasting (ACHIEVE-RAM)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07662083","publication_url":"https://clinicaltrials.gov/study/NCT07662083","title":"Randomized Controlled Trial Evaluating Trans Auricular Vagal Nerve Stimulation in Patients With Irritable Bowel Syndrome Constipation Subtype","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06564207","publication_url":"https://clinicaltrials.gov/study/NCT06564207","title":"Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study for the Long Term Evaluation of Fostamatinib for the Treatment of Adult Patients With Acute Respiratory Distress Syndrome (ARDS)","has_exemption":false,"start_date":"2026-08-30","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07549451","publication_url":"https://clinicaltrials.gov/study/NCT07549451","title":"Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms","has_exemption":false,"start_date":"2026-10-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07581314","publication_url":"https://clinicaltrials.gov/study/NCT07581314","title":"A First-in-Human (FIH), Phase I/II, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of Zn-Telomir Administered Orally as Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Telomir Pharmaceuticals, Inc.","sponsor_slug":"telomir-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07487454","publication_url":"https://clinicaltrials.gov/study/NCT07487454","title":"Sham-Controlled Rapid-Acting Neuromodulation for Depression","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03466476","publication_url":"https://clinicaltrials.gov/study/NCT03466476","title":"Evaluating the Efficacy of the TracPatch Wearable Technology on Patients Undergoing Total Knee Arthroplasty (TKA)","has_exemption":false,"start_date":"2017-03-20","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02997228","publication_url":"https://clinicaltrials.gov/study/NCT02997228","title":"Colorectal Cancer Metastatic dMMR/MSI-H Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination Versus Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2018-01-19","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03322995","publication_url":"https://clinicaltrials.gov/study/NCT03322995","title":"Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients With Localized Pancreatic Cancer","has_exemption":false,"start_date":"2018-06-21","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03598257","publication_url":"https://clinicaltrials.gov/study/NCT03598257","title":"A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer","has_exemption":false,"start_date":"2019-01-18","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03520647","publication_url":"https://clinicaltrials.gov/study/NCT03520647","title":"Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis","has_exemption":false,"start_date":"2019-02-19","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03922724","publication_url":"https://clinicaltrials.gov/study/NCT03922724","title":"Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma","has_exemption":false,"start_date":"2019-04-18","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03906422","publication_url":"https://clinicaltrials.gov/study/NCT03906422","title":"Comparison of Patient-reported Pain After Initial Archwire Placement With Three Types of Nickel-titanium Archwires: a Prospective Triple-blind, Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2019-05-10","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03775265","publication_url":"https://clinicaltrials.gov/study/NCT03775265","title":"Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2019-06-03","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03907475","publication_url":"https://clinicaltrials.gov/study/NCT03907475","title":"DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination With Chemotherapy in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2019-07-16","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04505618","publication_url":"https://clinicaltrials.gov/study/NCT04505618","title":"Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease","has_exemption":false,"start_date":"2019-10-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04040205","publication_url":"https://clinicaltrials.gov/study/NCT04040205","title":"Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration","has_exemption":false,"start_date":"2019-10-07","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04291378","publication_url":"https://clinicaltrials.gov/study/NCT04291378","title":"The DBCG Proton Trial. Adjuvant Breast Proton Radiation Therapy for Early Breast Cancer Patients: The Skagen Trial 2, a Clinically Controlled Randomised Phase III Trial","has_exemption":false,"start_date":"2020-06-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Danish Breast Cancer Cooperative Group","sponsor_slug":"danish-breast-cancer-cooperative-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04379596","publication_url":"https://clinicaltrials.gov/study/NCT04379596","title":"A Phase 1b/2 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Trastuzumab Deruxtecan (T-DXd) Monotherapy and Combinations in Adult Participants With HER2-expressing Gastric Cancer (DESTINY-Gastric-03)","has_exemption":false,"start_date":"2020-06-03","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04373057","publication_url":"https://clinicaltrials.gov/study/NCT04373057","title":"A Phase I/II Trial of the Prebiotic Galacto-oligosaccharide to Prevent Acute GVHD","has_exemption":false,"start_date":"2021-01-22","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05273190","publication_url":"https://clinicaltrials.gov/study/NCT05273190","title":"Vibrotactile Stimulation of the Larynx to Treat Unexplained Chronic Cough","has_exemption":false,"start_date":"2021-07-13","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05055297","publication_url":"https://clinicaltrials.gov/study/NCT05055297","title":"SELUTION SLR™ 014 BTK: A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patients With Chronic Limb Threatening Ischemia (CLTI)","has_exemption":false,"start_date":"2022-05-19","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"M.A. Med Alliance S.A.","sponsor_slug":"ma-med-alliance-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05539716","publication_url":"https://clinicaltrials.gov/study/NCT05539716","title":"Metabolism and Sleep Apnea Treatment","has_exemption":false,"start_date":"2022-05-20","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05379868","publication_url":"https://clinicaltrials.gov/study/NCT05379868","title":"Posterior Column Spinal Osteotomies in the Treatment of Adolescent Idiopathic Scoliosis. A Randomized Clinical Trial","has_exemption":false,"start_date":"2022-06-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Turku University Hospital","sponsor_slug":"turku-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05366829","publication_url":"https://clinicaltrials.gov/study/NCT05366829","title":"Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma","has_exemption":false,"start_date":"2022-07-25","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317858","publication_url":"https://clinicaltrials.gov/study/NCT05317858","title":"A Randomized Pivotal Study Assessing the Safety and Efficacy of Targeted Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound During the Standard of Care Treatment of Brain Metastases of Non-small Cell Lung Cancer (NSCLC) Origin","has_exemption":false,"start_date":"2022-08-12","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05331144","publication_url":"https://clinicaltrials.gov/study/NCT05331144","title":"Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid, and Tau in Older Adults (IPAT Study)","has_exemption":false,"start_date":"2022-10-25","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Rong Zhang","sponsor_slug":"rong-zhang","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05345002","publication_url":"https://clinicaltrials.gov/study/NCT05345002","title":"A Phase 2 Trial of All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma","has_exemption":false,"start_date":"2022-11-16","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Stephen Bagley, MD, MSCE","sponsor_slug":"stephen-bagley-md-msce","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05084196","publication_url":"https://clinicaltrials.gov/study/NCT05084196","title":"Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury","has_exemption":false,"start_date":"2023-06-05","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05754632","publication_url":"https://clinicaltrials.gov/study/NCT05754632","title":"The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-06-08","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Connecticut Children's Medical Center","sponsor_slug":"connecticut-childrens-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05351229","publication_url":"https://clinicaltrials.gov/study/NCT05351229","title":"Intrathecal Morphine for Postoperative Analgesia in Video-Assisted and Robotic-Assisted Thoracic Surgery: A Randomized, Placebo-controlled, Double-blinded Clinical Trial","has_exemption":false,"start_date":"2023-09-29","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06071845","publication_url":"https://clinicaltrials.gov/study/NCT06071845","title":"Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples for the Non-endoscopic Detection of Barrett's Esophagus With and Without Dysplasia","has_exemption":false,"start_date":"2023-10-16","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05850091","publication_url":"https://clinicaltrials.gov/study/NCT05850091","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","has_exemption":false,"start_date":"2023-12-07","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05763953","publication_url":"https://clinicaltrials.gov/study/NCT05763953","title":"The NODE-202 Study Multi-Center, Multi-National, Open-Label, Efficacy and Safety Study of Etripamil Nasal Spray in Pediatric Patients With Paroxysmal Supraventricular Tachycardia","has_exemption":false,"start_date":"2023-12-11","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Milestone Pharmaceuticals Inc.","sponsor_slug":"milestone-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06253130","publication_url":"https://clinicaltrials.gov/study/NCT06253130","title":"A First-in-human, Phase 1/2, Open-label, Multi-center, Dose-escalation, Dose-optimization, and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of PARP1 Selective Inhibitor, IMP1734, as Monotherapy in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-12-11","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Eikon Therapeutics","sponsor_slug":"eikon-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05458674","publication_url":"https://clinicaltrials.gov/study/NCT05458674","title":"A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer","has_exemption":false,"start_date":"2024-01-30","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Criterium, Inc.","sponsor_slug":"criterium-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06417385","publication_url":"https://clinicaltrials.gov/study/NCT06417385","title":"Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)-Paired Breastfeeding to Improve Breastfeeding at Discharge","has_exemption":false,"start_date":"2024-02-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06266793","publication_url":"https://clinicaltrials.gov/study/NCT06266793","title":"Comparison of Lumenis Pulse 120H Moses 2.0 Holmium Laser vs. Olympus Soltive Thulium Fiber Laser for Mini-percutaneous Nephrolithotomy","has_exemption":false,"start_date":"2024-03-07","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"MaineHealth","sponsor_slug":"mainehealth","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05665361","publication_url":"https://clinicaltrials.gov/study/NCT05665361","title":"A Phase I/II Study of Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)","has_exemption":false,"start_date":"2024-04-24","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06307548","publication_url":"https://clinicaltrials.gov/study/NCT06307548","title":"Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Loco-Regionally Advanced or Recurrent Colorectal Cancer Undergoing Surgery - Phase I/II","has_exemption":false,"start_date":"2024-07-30","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06235112","publication_url":"https://clinicaltrials.gov/study/NCT06235112","title":"AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention: A Multicenter Randomized Trial","has_exemption":false,"start_date":"2024-07-31","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05330182","publication_url":"https://clinicaltrials.gov/study/NCT05330182","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence","has_exemption":false,"start_date":"2024-08-29","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Lumen Bioscience, Inc.","sponsor_slug":"lumen-bioscience-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06388564","publication_url":"https://clinicaltrials.gov/study/NCT06388564","title":"A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease","has_exemption":false,"start_date":"2024-10-11","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311591","publication_url":"https://clinicaltrials.gov/study/NCT06311591","title":"Evaluation of Efficacy, Effectiveness, and Implementation of Jaspr Health's Digital Platform in Emergency Department for Patients With Suicidal Risk - Part B: Real-World Study (RWS)","has_exemption":false,"start_date":"2024-11-07","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Massachusetts, Worcester","sponsor_slug":"university-of-massachusetts-worcester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07385651","publication_url":"https://clinicaltrials.gov/study/NCT07385651","title":"Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage","has_exemption":false,"start_date":"2024-11-18","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06532006","publication_url":"https://clinicaltrials.gov/study/NCT06532006","title":"A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination With Trastuzumab and Chemotherapy (XELOX) Versus Trastuzumab and Chemotherapy (XELOX) With or Without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer","has_exemption":false,"start_date":"2024-11-22","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Shanghai Henlius Biotech","sponsor_slug":"shanghai-henlius-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06578741","publication_url":"https://clinicaltrials.gov/study/NCT06578741","title":"GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study","has_exemption":false,"start_date":"2024-11-25","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06656325","publication_url":"https://clinicaltrials.gov/study/NCT06656325","title":"An Evaluation of the Effect of the Erchonia Corporation FX-405 Laser as an Adjunctive Treatment of Periodontitis","has_exemption":false,"start_date":"2025-01-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Erchonia Corporation","sponsor_slug":"erchonia-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06694714","publication_url":"https://clinicaltrials.gov/study/NCT06694714","title":"Characterizing and Comparing the Duration of Local Anesthetic in Dermatologic Surgery - Fourth Arm","has_exemption":false,"start_date":"2025-01-21","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06545643","publication_url":"https://clinicaltrials.gov/study/NCT06545643","title":"Personalized Risk Assessment of Seizures Sensitive to Poor Sleep: a Longitudinal Study Using Wearable Electroencephalography Devices","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06936566","publication_url":"https://clinicaltrials.gov/study/NCT06936566","title":"Phase 2 Study of Ruxolitinib-Based Primary Treatment for Acute GVHD","has_exemption":false,"start_date":"2025-05-14","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"John Levine","sponsor_slug":"john-levine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07199855","publication_url":"https://clinicaltrials.gov/study/NCT07199855","title":"Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia：a Prospective，Single-arm Study","has_exemption":false,"start_date":"2025-06-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Zhejiang University","sponsor_slug":"zhejiang-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020650","publication_url":"https://clinicaltrials.gov/study/NCT07020650","title":"The Effectiveness of Carbonate Apatite Bone Graft for Alveolar Ridge Preservation: A Clinical, Radiographic, and Histomorphometric Study","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07564388","publication_url":"https://clinicaltrials.gov/study/NCT07564388","title":"Cochlear-Implant-Performance-Prediction","has_exemption":false,"start_date":"2025-06-25","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06989762","publication_url":"https://clinicaltrials.gov/study/NCT06989762","title":"Use of an Intraabdominal Pressure Monitoring Urinary Catheter After Cardiac Surgery to Improve Kidney Perfusion Pressure: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-08-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Dang Tan Phat","sponsor_slug":"dang-tan-phat","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07087678","publication_url":"https://clinicaltrials.gov/study/NCT07087678","title":"A Prospective, Randomised, Open Label Feasibility Trial Comparing BurstDR Microdosing Versus Tonic Occipital Nerve Stimulation for Patients With Refractory Chronic Migraine","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University College, London","sponsor_slug":"university-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032727","publication_url":"https://clinicaltrials.gov/study/NCT07032727","title":"Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations","has_exemption":false,"start_date":"2025-09-12","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06710431","publication_url":"https://clinicaltrials.gov/study/NCT06710431","title":"A Double-blind, Placebo-controlled, Phase IIA Human Laboratory Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Afasci Inc","sponsor_slug":"afasci-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032675","publication_url":"https://clinicaltrials.gov/study/NCT07032675","title":"Cartilage Remodeling Using Low-Temperature Radiofrequency for Facial Reconstruction","has_exemption":false,"start_date":"2025-10-14","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225764","publication_url":"https://clinicaltrials.gov/study/NCT07225764","title":"Empiric vs Selective Medical Therapy for Calcium Oxalate Stone Prevention: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-23","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07090005","publication_url":"https://clinicaltrials.gov/study/NCT07090005","title":"Comparing the Efficacy and Safety of the EndoZipTM System and Apollo Endoscopic Sleeve Gastroplasty (ESG), Followed by Behavioral Modifications, in Obese Patients Who Have Not Achieved Weight Reduction Through Non-surgical Methods.","has_exemption":false,"start_date":"2025-11-14","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Nitinotes Surgical Ltd.","sponsor_slug":"nitinotes-surgical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07231523","publication_url":"https://clinicaltrials.gov/study/NCT07231523","title":"Perioperative Efficacy and Safety of Efgartigimod Versus Intravenous Immunoglobulin for Thymoma Associated Myasthenia Gravis: a Prospective, Multicenter, Randomized Controlled Study","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Shanghai Zhongshan Hospital","sponsor_slug":"shanghai-zhongshan-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220525","publication_url":"https://clinicaltrials.gov/study/NCT07220525","title":"Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321704","publication_url":"https://clinicaltrials.gov/study/NCT07321704","title":"Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous Flap-Based Closure of Pilonidal Disease With Myriad Extracellular Matrix Implantation","has_exemption":false,"start_date":"2026-02-17","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Yosef Nasseri, MD","sponsor_slug":"yosef-nasseri-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07263035","publication_url":"https://clinicaltrials.gov/study/NCT07263035","title":"Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Lakeland Regional Health Systems, Inc.","sponsor_slug":"lakeland-regional-health-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07401225","publication_url":"https://clinicaltrials.gov/study/NCT07401225","title":"Transcranial Magnetic Stimulation as Treatment for Persistent PTSD in Texas Youth","has_exemption":false,"start_date":"2026-05-09","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07211035","publication_url":"https://clinicaltrials.gov/study/NCT07211035","title":"A Pivotal Study to Evaluate the Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and Arteriovenous Fistula Maturation","has_exemption":false,"start_date":"2026-05-12","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Amplifi Vascular, Inc.","sponsor_slug":"amplifi-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04383262","publication_url":"https://clinicaltrials.gov/study/NCT04383262","title":"A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy of Oral Fosamprenavir for Laryngopharyngeal Reflux","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07249346","publication_url":"https://clinicaltrials.gov/study/NCT07249346","title":"An Open Label, Non-Randomized, Multi-Center Pilot Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for GVHD Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Hannah Choe, MD","sponsor_slug":"hannah-choe-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07553364","publication_url":"https://clinicaltrials.gov/study/NCT07553364","title":"Feasibility of Using Alpha Phase-Locked Auditory Stimulation for Insomnia Symptoms in People With Depression","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07056699","publication_url":"https://clinicaltrials.gov/study/NCT07056699","title":"Protocol V: San Antonio Site Sub Study: Can Pioglitazone Block SGLT2 Inhibitor-induced Stimulation of Lipolysis, Ketone Production and Liver Glucose Production in Type I Diabetic Patients","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04003285","publication_url":"https://clinicaltrials.gov/study/NCT04003285","title":"Novel Regenerative Therapeutic in Chronic Complex TBI","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655142","publication_url":"https://clinicaltrials.gov/study/NCT06655142","title":"Prospective Matched Control Feasibility Study to Determine the Capacity of the Onco-Seraph 100 Microbind® Affinity Blood Filter ( ONCObind Procedure) to Remove Circulating Tumor Cells From the Blood in Patients With Either Metastatic Pancreatic Adenocarcinoma or Metastatic Colorectal Carcinoma","has_exemption":false,"start_date":"2027-01-15","completion_date":"2027-06-01","has_results":false,"results_due":false,"sponsor_name":"ExThera Medical Corporation","sponsor_slug":"exthera-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05263206","publication_url":"https://clinicaltrials.gov/study/NCT05263206","title":"Master Protocol of Two Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Studies to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Chronic Pruritus of Unknown Origin (CPUO)","has_exemption":false,"start_date":"2022-02-15","completion_date":"2027-06-02","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04783857","publication_url":"https://clinicaltrials.gov/study/NCT04783857","title":"Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children","has_exemption":false,"start_date":"2022-04-14","completion_date":"2027-06-02","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05868265","publication_url":"https://clinicaltrials.gov/study/NCT05868265","title":"Neoadjuvant Enfortumab Vedotin in High-Grade Urothelial Carcinoma of the Upper Urinary Tract (Including Ureter and Renal Pelvis)","has_exemption":false,"start_date":"2023-06-02","completion_date":"2027-06-02","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06401356","publication_url":"https://clinicaltrials.gov/study/NCT06401356","title":"An Open-Label, Multicenter, Extension Study for Patients Previously Enrolled in Studies With Pelabresib","has_exemption":false,"start_date":"2024-08-13","completion_date":"2027-06-02","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04679844","publication_url":"https://clinicaltrials.gov/study/NCT04679844","title":"A Prospective, Randomized, Multi-Center Study to Assess the Safety and Performance of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers (DBX or Grafton) Mixed With Local Autograft in Patients Undergoing One to Two-Level Instrumented Posterolateral Lumbar/Thoracolumbar Fusion (PLF)","has_exemption":false,"start_date":"2024-12-06","completion_date":"2027-06-02","has_results":false,"results_due":false,"sponsor_name":"Kuros Biosurgery AG","sponsor_slug":"kuros-biosurgery-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06840392","publication_url":"https://clinicaltrials.gov/study/NCT06840392","title":"A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE-2)","has_exemption":false,"start_date":"2025-03-20","completion_date":"2027-06-03","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06962306","publication_url":"https://clinicaltrials.gov/study/NCT06962306","title":"Perioperative Methadone Use for Cleft Palate Repair: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-04","completion_date":"2027-06-04","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05934448","publication_url":"https://clinicaltrials.gov/study/NCT05934448","title":"A Phase II Trial of Pembrolizumab in Combination With Chimeric Antigen Receptor Therapy in Patients With Relapsed/Refractory Primary Mediastinal B-cell Lymphoma","has_exemption":false,"start_date":"2023-11-15","completion_date":"2027-06-06","has_results":false,"results_due":false,"sponsor_name":"Jennifer Crombie, MD","sponsor_slug":"jennifer-crombie-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06653192","publication_url":"https://clinicaltrials.gov/study/NCT06653192","title":"Endoscopic Ultrasound-Guided Biliary Drainage With Lumen-Apposing Stent vs Classical ERCP for First-line Therapy of Malignant Distal Biliary Obstruction: An Open-label, Multicenter Randomized Trial (CARPEDIEM Trial)","has_exemption":false,"start_date":"2025-05-06","completion_date":"2027-06-06","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitari de Bellvitge","sponsor_slug":"hospital-universitari-de-bellvitge","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05899049","publication_url":"https://clinicaltrials.gov/study/NCT05899049","title":"An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, as First-Line Treatment in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)","has_exemption":false,"start_date":"2022-07-27","completion_date":"2027-06-07","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06183931","publication_url":"https://clinicaltrials.gov/study/NCT06183931","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Amyloid Depleter ALXN2220 in Adult Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)","has_exemption":false,"start_date":"2024-01-11","completion_date":"2027-06-07","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07348692","publication_url":"https://clinicaltrials.gov/study/NCT07348692","title":"A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, Lot-to-lot Consistency, 4-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers","has_exemption":false,"start_date":"2026-01-20","completion_date":"2027-06-07","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06408935","publication_url":"https://clinicaltrials.gov/study/NCT06408935","title":"A Phase 3b, Open-label, Multicenter Study to Evaluate Transmural Healing and Disease Modifying Effect of Guselkumab in Crohn's Disease Patients","has_exemption":false,"start_date":"2024-04-17","completion_date":"2027-06-08","has_results":false,"results_due":false,"sponsor_name":"Janssen-Cilag Ltd.","sponsor_slug":"janssen-cilag-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06227910","publication_url":"https://clinicaltrials.gov/study/NCT06227910","title":"A Randomized, Double-Blind, Phase 3b Study to Evaluate the Short- and Long-Term Efficacy and Safety of Dual Targeted Therapy With Intravenous Vedolizumab and Oral Upadacitinib Compared With Intravenous Vedolizumab and Oral Placebo for Induction Followed by Intravenous Vedolizumab Monotherapy for Maintenance in the Treatment of Adults With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2025-01-02","completion_date":"2027-06-08","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02584933","publication_url":"https://clinicaltrials.gov/study/NCT02584933","title":"An Open-label, Multi-center, Phase IV Roll-over Study in Patients With ALK Positive Malignancies Who Have Completed a Novartis-sponsored Ceritinib (LDK378) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Ceritinib","has_exemption":false,"start_date":"2015-12-11","completion_date":"2027-06-09","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05477563","publication_url":"https://clinicaltrials.gov/study/NCT05477563","title":"A Phase 3b Study to Evaluate Efficacy and Safety of a Single Dose of Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Transfusion-Dependent β-Thalassemia or Severe Sickle Cell Disease","has_exemption":false,"start_date":"2022-08-02","completion_date":"2027-06-09","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05912244","publication_url":"https://clinicaltrials.gov/study/NCT05912244","title":"A Phase II Study of IO102/IO103 and Nivolumab-relatlimab Fixed Dose Combination in Untreated, Unresectable Stage III/IV Melanoma","has_exemption":false,"start_date":"2023-06-09","completion_date":"2027-06-09","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03314974","publication_url":"https://clinicaltrials.gov/study/NCT03314974","title":"Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases","has_exemption":false,"start_date":"2018-03-30","completion_date":"2027-06-10","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05419076","publication_url":"https://clinicaltrials.gov/study/NCT05419076","title":"A Single Arm Phase II Study Assessing Efficacy of Stereotactic Radiosurgery (SRS) for Brain Metastasis (BM) From Small Cell Lung Cancer (SCLC)","has_exemption":false,"start_date":"2022-06-10","completion_date":"2027-06-10","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04199741","publication_url":"https://clinicaltrials.gov/study/NCT04199741","title":"Immuno-PET Imaging of Neuroendocrine Tumors Using 89Zr-DFO-SC16.56, a DLL3-targeting Monoclonal Antibody","has_exemption":false,"start_date":"2019-12-11","completion_date":"2027-06-11","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05319730","publication_url":"https://clinicaltrials.gov/study/NCT05319730","title":"A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer Previously Exposed to PD-1/PD-L1 Treatment (KEYMAKER-U06): Substudy 06B","has_exemption":false,"start_date":"2023-05-16","completion_date":"2027-06-11","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06307652","publication_url":"https://clinicaltrials.gov/study/NCT06307652","title":"A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared With Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients With Heart Failure and Impaired Kidney Function","has_exemption":false,"start_date":"2024-04-12","completion_date":"2027-06-11","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07108387","publication_url":"https://clinicaltrials.gov/study/NCT07108387","title":"A Randomized Study of Tocilizumab Discontinuation for Patients With Giant Cell Arteritis in Remission (AGA01)","has_exemption":false,"start_date":"2025-12-11","completion_date":"2027-06-11","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07405151","publication_url":"https://clinicaltrials.gov/study/NCT07405151","title":"A Phase 2 Open-Label, Umbrella Platform Design Study of Investigational Agent(s) in Participants With 2L/3L Unresectable Locally Advanced or Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06F","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-06-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07266441","publication_url":"https://clinicaltrials.gov/study/NCT07266441","title":"A Phase 2, Open-label Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Who Have Received at Least 3 Prior Lines of Therapy Including a PI, an IMiD, and an Anti-CD38 Antibody","has_exemption":false,"start_date":"2026-02-08","completion_date":"2027-06-14","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07012031","publication_url":"https://clinicaltrials.gov/study/NCT07012031","title":"A Phase I/II Study Evaluating the Safety, Tolerability, and Efficacy of Sotorasib Plus Trastuzumab Deruxtecan in Patients With Advanced Non-Small Cell Lung Cancer With a KRASG12C Mutation","has_exemption":false,"start_date":"2026-06-17","completion_date":"2027-06-14","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04348747","publication_url":"https://clinicaltrials.gov/study/NCT04348747","title":"A Phase IIa Study of Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab in Patients With Asymptomatic Brain Metastasis From Triple Negative Breast Cancer (TNBC) or HER2+ Breast Cancer (HER2+BC) or Hormone Receptor Positive (HR+) Breast Cancer.","has_exemption":false,"start_date":"2022-12-19","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06047535","publication_url":"https://clinicaltrials.gov/study/NCT06047535","title":"Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response. A Single-Arm, Multicenter Clinical Trial","has_exemption":false,"start_date":"2023-10-31","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"SciClone Pharmaceuticals","sponsor_slug":"sciclone-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333509","publication_url":"https://clinicaltrials.gov/study/NCT06333509","title":"A Phase 1/2 Open Label Study to Evaluate the Safety and Efficacy of CT071, an Autologous Anti-GPRC5D CAR T, in Relapsed/Refractory Multiple Myeloma (RRMM) or Relapsed/Refractory Primary Plasma Cell Leukemia (RRpPCL)","has_exemption":false,"start_date":"2024-04-15","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"CARsgen Therapeutics Co., Ltd.","sponsor_slug":"carsgen-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305715","publication_url":"https://clinicaltrials.gov/study/NCT06305715","title":"Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)","has_exemption":false,"start_date":"2024-09-18","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06422923","publication_url":"https://clinicaltrials.gov/study/NCT06422923","title":"A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Temporal Lobe Epilepsy (MTLE)","has_exemption":false,"start_date":"2024-11-14","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"Neurona Therapeutics","sponsor_slug":"neurona-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07133633","publication_url":"https://clinicaltrials.gov/study/NCT07133633","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)","has_exemption":false,"start_date":"2025-09-26","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06517797","publication_url":"https://clinicaltrials.gov/study/NCT06517797","title":"Phase IIb Placebo-Controlled Double-Blind Randomized Parallel Groups Study to Determine the Efficacy and Safety of S1B-509 for Weight Loss","has_exemption":false,"start_date":"2025-10-15","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"S1 Biopharma, Inc.","sponsor_slug":"s1-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07239336","publication_url":"https://clinicaltrials.gov/study/NCT07239336","title":"A Phase II, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate The Efficacy and Safety of DONQ52 in Active Celiac Disease Patients Who Have Duodenal Mucosal Damage and Persistent Symptoms Despite Attempting A Gluten-free Diet (DAISY STUDY)","has_exemption":false,"start_date":"2025-12-16","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"Chugai Pharmaceutical","sponsor_slug":"chugai-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07452549","publication_url":"https://clinicaltrials.gov/study/NCT07452549","title":"Safety and Effectiveness of TETRANITE Bone Adhesive for Cranial Flap Fixation Compared to Traditional Metal Hardware","has_exemption":false,"start_date":"2026-04-15","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"RevBio","sponsor_slug":"revbio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07574541","publication_url":"https://clinicaltrials.gov/study/NCT07574541","title":"Phase II Trial of a Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06137638","publication_url":"https://clinicaltrials.gov/study/NCT06137638","title":"A Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Efficacy of ENA-001 in Preventing Postoperative Respiratory Depression","has_exemption":false,"start_date":"2026-12-15","completion_date":"2027-06-15","has_results":false,"results_due":false,"sponsor_name":"Enalare Therapeutics Inc.","sponsor_slug":"enalare-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06282042","publication_url":"https://clinicaltrials.gov/study/NCT06282042","title":"Early Transcatheter Mitral Valve Repair After Myocardial Infarction","has_exemption":false,"start_date":"2024-12-24","completion_date":"2027-06-16","has_results":false,"results_due":false,"sponsor_name":"Fundación para la Investigación Biosanitaria del Principado de Asturias","sponsor_slug":"fundacion-para-la-investigacion-biosanitaria-del-principado-de-asturias","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07266558","publication_url":"https://clinicaltrials.gov/study/NCT07266558","title":"A Phase 4, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of mRNA-1283 And mRNA-1273 Variant-Containing Formulation in Adults 50 to 64 Years of Age Without Underlying Conditions That Put Them at High Risk for Severe Outcomes From COVID-19","has_exemption":false,"start_date":"2025-11-26","completion_date":"2027-06-16","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06620523","publication_url":"https://clinicaltrials.gov/study/NCT06620523","title":"Efficacy of Mitochondrial Directed Therapy in Prevention of Cardiac Surgery Associated AKI Prevent Cardiac Surgery Associated AKI Trial (Prevent CSA-AKI Trial)","has_exemption":false,"start_date":"2024-07-18","completion_date":"2027-06-17","has_results":false,"results_due":false,"sponsor_name":"George Washington University","sponsor_slug":"george-washington-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06980077","publication_url":"https://clinicaltrials.gov/study/NCT06980077","title":"UCLA L-11: A Phase II Trial of Ivonescimab for Previously Treated Thymic Carcinoma","has_exemption":false,"start_date":"2025-07-15","completion_date":"2027-06-17","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220772","publication_url":"https://clinicaltrials.gov/study/NCT07220772","title":"An Open-Label Study of Mibavademab (REGN4461), a Leptin Receptor Agonist, for the Treatment of Monogenic Obesity Due to Biallelic Loss of Function Variants of the LEP Gene","has_exemption":false,"start_date":"2026-02-09","completion_date":"2027-06-18","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05758545","publication_url":"https://clinicaltrials.gov/study/NCT05758545","title":"Concurrent Optical and Magnetic Stimulation (COMS) for Treatment of Refractory Diabetic Foot Ulcer; a Prospective Randomized, Sham-controlled, Double-blinded, Pivotal Clinical Trial","has_exemption":false,"start_date":"2023-06-19","completion_date":"2027-06-19","has_results":false,"results_due":false,"sponsor_name":"Piomic Medical","sponsor_slug":"piomic-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05422534","publication_url":"https://clinicaltrials.gov/study/NCT05422534","title":"Role of Mitochondrial Dysfunction in the Response to Exercise in Patients With Advance Kidney Disease","has_exemption":false,"start_date":"2023-06-01","completion_date":"2027-06-20","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06105892","publication_url":"https://clinicaltrials.gov/study/NCT06105892","title":"Eye Recovery Automation for Post Injury Dysfunction","has_exemption":false,"start_date":"2023-10-23","completion_date":"2027-06-20","has_results":false,"results_due":false,"sponsor_name":"New Jersey Institute of Technology","sponsor_slug":"new-jersey-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06598007","publication_url":"https://clinicaltrials.gov/study/NCT06598007","title":"A Phase 1/2 First-In-Human, Open-Label, Multicenter, Dose Escalation and Dose Expansion Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CT3001 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-09-20","completion_date":"2027-06-20","has_results":false,"results_due":false,"sponsor_name":"Crossignal Therapeutics, Inc.","sponsor_slug":"crossignal-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07163273","publication_url":"https://clinicaltrials.gov/study/NCT07163273","title":"Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2025-06-20","completion_date":"2027-06-20","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06796907","publication_url":"https://clinicaltrials.gov/study/NCT06796907","title":"A Phase 1/2 Randomized Multi-Cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-03-04","completion_date":"2027-06-21","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04998552","publication_url":"https://clinicaltrials.gov/study/NCT04998552","title":"Safety and Efficacy of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma: Open Label Prospective Randomized Clinical Trial","has_exemption":false,"start_date":"2021-06-22","completion_date":"2027-06-22","has_results":false,"results_due":false,"sponsor_name":"Capital Health System, Inc","sponsor_slug":"capital-health-system-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05126277","publication_url":"https://clinicaltrials.gov/study/NCT05126277","title":"A Randomized, Double-blind, Parallel Group, Placebo-controlled, Multicenter Phase 3 Trial to Evaluate Efficacy, Safety and Tolerability of Ianalumab on Top of Standard-of-care Therapy in Participants With Active Lupus Nephritis (SIRIUS-LN).","has_exemption":false,"start_date":"2022-07-14","completion_date":"2027-06-22","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06995352","publication_url":"https://clinicaltrials.gov/study/NCT06995352","title":"Liposomal Bupivacaine Versus Continuous Peripheral Nerve Blocks for Analgesia Following Ankle Surgery: A Randomized, Observer and Participant Masked, Active Control, Non-Inferiority Study","has_exemption":false,"start_date":"2025-06-23","completion_date":"2027-06-22","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07182240","publication_url":"https://clinicaltrials.gov/study/NCT07182240","title":"Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas","has_exemption":false,"start_date":"2025-12-22","completion_date":"2027-06-22","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431853","publication_url":"https://clinicaltrials.gov/study/NCT07431853","title":"A PHASE 2, RANDOMIZED, DOUBLE-BLIND, CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MRNA VACCINES AGAINST INFLUENZA IN ADULTS 18 YEARS OF AGE AND OLDER","has_exemption":false,"start_date":"2026-02-23","completion_date":"2027-06-22","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03731260","publication_url":"https://clinicaltrials.gov/study/NCT03731260","title":"A 3-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Safety and Efficacy of Avapritinib (BLU-285), a Selective KIT Mutation-Targeted Tyrosine Kinase Inhibitor, in Indolent and Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy","has_exemption":false,"start_date":"2019-04-16","completion_date":"2027-06-23","has_results":false,"results_due":false,"sponsor_name":"Blueprint Medicines Corporation","sponsor_slug":"blueprint-medicines-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05445609","publication_url":"https://clinicaltrials.gov/study/NCT05445609","title":"A Single Arm Study of Vidutolimod (CMP-001) With Nivolumab in Patients With Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-06-07","completion_date":"2027-06-23","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07311564","publication_url":"https://clinicaltrials.gov/study/NCT07311564","title":"A Phase 2, Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate Efficacy and Safety of LAD603 in Adult Subjects With Severe to Very Severe Alopecia Areata","has_exemption":false,"start_date":"2025-12-17","completion_date":"2027-06-23","has_results":false,"results_due":false,"sponsor_name":"Almirall, S.A.","sponsor_slug":"almirall-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07665294","publication_url":"https://clinicaltrials.gov/study/NCT07665294","title":"CURVE-UC: A Pragmatic Randomized, Double-blind, Placebo Controlled, Treat-through, Multi-site Pragmatic Interventional Study to Evaluate the Efficacy and Safety of Combination Curcumin-QingDai (CurQD) With Vedolizumab in Moderate to Severe Ulcerative Colitis (UC)","has_exemption":false,"start_date":"2026-06-24","completion_date":"2027-06-23","has_results":false,"results_due":false,"sponsor_name":"Ryan C Ungaro","sponsor_slug":"ryan-c-ungaro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03523975","publication_url":"https://clinicaltrials.gov/study/NCT03523975","title":"Phase I/II Multi-site Study Evaluating the MTD, Safety and Efficacy of the Combination Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma","has_exemption":false,"start_date":"2018-12-24","completion_date":"2027-06-24","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06147986","publication_url":"https://clinicaltrials.gov/study/NCT06147986","title":"A Phase IIa, Dose-Escalation Followed by Randomized, Open-Label, Parallel-Group Study to Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells As an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients","has_exemption":false,"start_date":"2023-09-24","completion_date":"2027-06-24","has_results":false,"results_due":false,"sponsor_name":"Ever Supreme Bio Technology Co., Ltd.","sponsor_slug":"ever-supreme-bio-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06932263","publication_url":"https://clinicaltrials.gov/study/NCT06932263","title":"A Phase IIb, Multicentre, Double-blind, Placebo-controlled Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adult Participants With Uncontrolled Asthma on Medium-to High Dose Inhaled Corticosteroids","has_exemption":false,"start_date":"2025-03-26","completion_date":"2027-06-24","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655883","publication_url":"https://clinicaltrials.gov/study/NCT06655883","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Suvorexant for the Treatment of Insomnia in Participants With Opioid Use Disorder","has_exemption":false,"start_date":"2025-10-09","completion_date":"2027-06-24","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05949684","publication_url":"https://clinicaltrials.gov/study/NCT05949684","title":"A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) vs Epoetin Alfa for the Treatment of Anemia Due to Revised International Prognostic Scoring System (IPSS-R) Very Low, Low, or Intermediate-Risk Myelodysplastic Syndrome (MDS) in Erythropoiesis-Stimulating Agent (ESA)-Naive Participants Who Are Non-Transfusion Dependent (NTD): The \"ELEMENT-MDS\" Trial","has_exemption":false,"start_date":"2023-10-24","completion_date":"2027-06-25","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06433011","publication_url":"https://clinicaltrials.gov/study/NCT06433011","title":"The RAPID - PE Study: RESCUE Advanced Protocol Without ICU Stay and no Lytic Drip - for the Treatment of Pulmonary Embolism","has_exemption":false,"start_date":"2024-06-25","completion_date":"2027-06-25","has_results":false,"results_due":false,"sponsor_name":"Thrombolex, Inc.","sponsor_slug":"thrombolex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06473779","publication_url":"https://clinicaltrials.gov/study/NCT06473779","title":"A Multicentre, Randomised, Open-Label, Parallel-Group, Phase IIIb Study to Assess the Potential for Tezepelumab-treated Patients With Severe Asthma to Reduce Background Therapy While Sustaining Asthma Control and Clinical Remission","has_exemption":false,"start_date":"2024-09-30","completion_date":"2027-06-25","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07053345","publication_url":"https://clinicaltrials.gov/study/NCT07053345","title":"An Interventional, Open-label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of Esketamine Nasal Spray in Korean Participants With Treatment-Resistant Depression(TRD)","has_exemption":false,"start_date":"2025-06-09","completion_date":"2027-06-25","has_results":false,"results_due":false,"sponsor_name":"Janssen Korea, Ltd., Korea","sponsor_slug":"janssen-korea-ltd-korea","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215390","publication_url":"https://clinicaltrials.gov/study/NCT07215390","title":"A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneration","has_exemption":false,"start_date":"2025-06-23","completion_date":"2027-06-25","has_results":false,"results_due":false,"sponsor_name":"Apellis Pharmaceuticals, Inc.","sponsor_slug":"apellis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06418958","publication_url":"https://clinicaltrials.gov/study/NCT06418958","title":"In Vivo Temperature Changes Caused by Exposure to Short- and Long-wavelengths","has_exemption":false,"start_date":"2025-09-22","completion_date":"2027-06-25","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776914","publication_url":"https://clinicaltrials.gov/study/NCT05776914","title":"Efficacy and Safety of Proteolytic Activity-Guided Fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT Trial)","has_exemption":false,"start_date":"2024-04-15","completion_date":"2027-06-26","has_results":false,"results_due":false,"sponsor_name":"Madhusudan (Madhu) Grover, MBBS","sponsor_slug":"madhusudan-madhu-grover-mbbs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06065449","publication_url":"https://clinicaltrials.gov/study/NCT06065449","title":"A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases","has_exemption":false,"start_date":"2024-01-24","completion_date":"2027-06-27","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05513859","publication_url":"https://clinicaltrials.gov/study/NCT05513859","title":"Towards In-Vivo, Intraoperative Image Guided Brain Tumor Margin Assessment With Quantitative Oblique Back Illumination Microscopy","has_exemption":false,"start_date":"2024-03-11","completion_date":"2027-06-28","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06045754","publication_url":"https://clinicaltrials.gov/study/NCT06045754","title":"An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Dual Targeted Therapy With Vedolizumab Intravenous (IV) and Adalimumab Subcutaneous (SC) or Vedolizumab IV and Ustekinumab IV/SC in Moderate to Severe Crohn's Disease (CD)","has_exemption":false,"start_date":"2024-04-18","completion_date":"2027-06-28","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null}]}